Next Article in Journal
Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia
Previous Article in Journal
Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 14
Issue 4
10.3390/v14040728
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model

by
Jurika Murakami
1,
Akihiro Shibata
2,
Gabriele Neumann
3,
Masaki Imai
1,4,
Tokiko Watanabe
1,5,6,* and
Yoshihiro Kawaoka
1,3,4,*
1
Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan
2
Exotic Disease Inspection Division, Laboratory Department, Animal Quarantine Service, Ministry of Agriculture, Forestry and Fisheries, Tokoname 479-0881, Japan
3
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin–Madison, Madison, WI 53706, USA
4
The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan
5
Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Japan
6
Center for Infectious Disease and Education and Research (CiDER), Osaka University, Suita 565-0871, Japan
*
Authors to whom correspondence should be addressed.
Viruses 2022, 14(4), 728; https://doi.org/10.3390/v14040728
Submission received: 1 March 2022 / Revised: 28 March 2022 / Accepted: 28 March 2022 / Published: 30 March 2022
(This article belongs to the Topic Strategies for Prevention and Control of Influenza)
Browse Figures
Versions Notes

Abstract

:
Low pathogenic H9N2 avian influenza viruses have spread in wild birds and poultry worldwide. Recently, the number of human cases of H9N2 virus infection has increased in China and other countries, heightening pandemic concerns. In Japan, H9N2 viruses are not yet enzootic; however, avian influenza viruses, including H5N1, H7N9, H5N6, and H9N2, have been repeatedly detected in raw poultry meat carried by international flight passengers from Asian countries to Japan. Although H9N2 virus-contaminated poultry products intercepted by the animal quarantine service at the Japan border have been characterized in chickens and ducks, the biological properties of those H9N2 viruses in mammals remain unclear. Here, we characterized the biological features of two H9N2 virus isolates [A/chicken/Japan/AQ-HE28-50/2016 (Ck/HE28-50) and A/chicken/Japan/AQ-HE28-57/2016 (Ck/HE28-57)] in a mouse model. We found that these H9N2 viruses replicate well in the respiratory tract of infected mice without adaptation, and that Ck/HE28-57 caused body weight loss in the infected mice. Our results indicate that H9N2 avian influenza viruses isolated from raw chicken meat products illegally brought to Japan can potentially infect and cause disease in mammals.

1. Introduction

H9N2 avian influenza viruses are of low pathogenicity in chickens but still cause mild respiratory symptoms and a drop in egg production, leading to economic losses in countries that rely on the poultry industry [1]. The H9N2 virus were first isolated in turkeys in the United States in 1966 [2,3]. Since the late 1990s, H9N2 viruses have been widespread in various species of wild birds and domestic poultry across the world, and have occasionally expanded their host range to mammalian species, such as pigs and humans [4]. The first case of human infection with a H9N2 virus was reported in China in 1998 [5]; since then, as of 20 December 2021, a total of 95 laboratory-confirmed cases of human infection with H9N2 viruses have been reported mainly in China, but also in other countries including Egypt, Bangladesh, Cambodia, Oman, Pakistan, India, and Senegal [6,7]. In addition, recent genetic analyses have revealed that H9N2 avian influenza viruses have contributed to the genetic and geographic diversity of H5N1 avian influenza viruses through genetic reassortment [8,9]. Furthermore, novel H7N9 avian influenza viruses, which emerged in 2013 and have infected a substantial number of people in China, are reassortants whose six internal genes come from H9N2 viruses [10]. Other subtypes of avian influenza viruses, such as H5N6, H5N8, and H10N8, can also possess the internal genes of H9N2 viruses due to genetic reassortment [11]. The worldwide distribution of H9N2 viruses with the ability to infect mammals and humans is increasing concern regarding their pandemic potential.
The HA gene of the H9N2 virus are classified into the Eurasian and American lineages. The Eurasian lineage is further classified into several sub-lineages, including A/duck/Hong Kong/Y280/1997 (Y280), A/quail/Hong Kong/G1/1997 (G1), and A/duck/Hong Kong/Y439/1997 (Y439). Y280-like viruses represent the dominant lineage in China and Southeast Asian countries. G1-like viruses have mainly circulated in South China, Central Asia, the Middle East, and North Africa, whereas Y439-like viruses have circulated in South Korea [12,13]. In Japan, H9N2 viruses are not yet enzootic. Therefore, careful surveillance of avian influenza viruses in poultry products carried by international flight passengers from other countries at the border is important to prevent their spread in Japan. Indeed, avian influenza viruses, including H5N1, H7N9, H5N6, and H9N2, have been repeatedly detected in raw poultry meat brought by international flight passengers from Asian countries to Japan [14,15]. Previous reports showed that seven H9N2 avian influenza viruses were isolated from chicken and duck meat products carried by passengers on flights from China and Vietnam; these viruses were classified into the Y280 sub-lineage [14,15]. One of these H9N2 viruses was characterized in avian models and found to be of low pathogenicity in chickens and ducks [14]; however, the biological properties of these H9N2 viruses in mammals remain unknown. Therefore, we here characterized the biological features of two H9N2 viruses [A/chicken/Japan/AQ-HE28-50/2016 (Ck/HE28-50) and A/chicken/Japan/AQ-HE28-57/2016 (Ck/HE28-57)] isolated from chicken meat products transported to Japan by international passengers from Vietnam [14] in a mouse model.

2. Materials and Methods

2.1. Cells

Madin-Darby canine kidney (MDCK) cells were maintained in minimal essential medium (MEM) containing 5% newborn calf serum, vitamins, essential amino acids, and antibiotics. Human lung adenocarcinoma epithelial A549 cells were grown in Ham’s F-12K containing 10% fetal bovine serum (FBS) with antibiotics. Chicken embryo fibroblast DF-1 cells were grown in Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) with antibiotics. MDCK and A549 cells were cultured at 37 °C with 5% CO2. DF-1 cells were cultured at 39 °C with 5% CO2 unless otherwise stated.

2.2. Viruses

Two H9N2 viruses [A/chicken/Japan/AQ-HE28-50/2016 (Ck/HE28-50) and A/chicken/Japan/AQ-HE28-57/2016 (Ck/HE28-57)], which were isolated from chicken meat products found in a traveler’s luggage in 2016 as previously described [14], were used in this study. To make viral stocks, Ck/HE28-50 and Ck/HE28-57 were propagated at 37 °C in 10-day-old, specific-pathogen-free embryonated chicken eggs for 48 h. Virus titers were determined by using plaque assays in MDCK cells.

2.3. Viral Genome Sequencing

Viral RNA was extracted from the supernatants of stock viruses by using a QIAamp viral RNA Mini Kit (Qiagen, Hilden, Germany). The first-strand cDNA was synthesized using Uni12 primer, Superscript III (Invitrogen, Carlsbad, CA, USA), and universal primers specific for influenza A virus genes [16]. The resulting products were PCR-amplified using Phusion DNA polymerase (NEW ENGLAND BioLabs, Tokyo, Japan) with specific primers for each virus gene. The amplified PCR products were purified and subjected to direct sequencing using the ABI PRISM 310 system.

2.4. Viral Replication Assay

Triplicate wells of confluent MDCK and A549 cells were infected with viruses at a multiplicity of infection (MOI) of 0.001 and incubated for 1 h at 37 °C. After the 1 h incubation, the MDCK and A549 cells were incubated in MEM and Ham’s F-12K containing 0.3% bovine serum albumin (BSA) at 37 °C, respectively. Triplicate wells of confluent DF-1 cells were infected with viruses at an MOI of 0.001, incubated for 1 h at 39 °C, and then incubated in DMEM containing 0.3% BSA at 39 °C. For the MDCK and DF-1 cells, aliquots of supernatants were harvested at 12 h post-infection (hpi), 24 hpi, and 48 hpi. For the A549 cells, aliquots of supernatants were harvested at 24-h intervals. Virus titers in the culture supernatants at each time point were determined utilizing plaque assays in MDCK cells.

2.5. Mouse Experiments

Female, six-week-old C57BL/6J mice (Japan SLC) were used for these experiments. To observe body weight changes, 5 mice/group for each virus were anesthetized with isoflurane and inoculated intranasally with 106 PFU/mouse in a 50-μL volume. The mice were monitored daily for clinical signs of infection and checked for changes in body weight and mortality for 14 days post-infection (dpi). Mice were euthanized if they lost more than 25% of their initial body weight. The remaining mice were euthanized at 14 dpi. For virus replication assessment, groups (3 mice/group) were infected intranasally with 104 or 106 PFU/mouse in a 50-μL volume. Three mice in each group were euthanized on Days 3 and 6 post-infection. Organs (lungs and nasal turbinates) were collected for virus titration in plaque assays in MDCK cells. The data shown are the mean virus titers ± standard deviations (SD). All experiments with mice were performed in accordance with the University of Tokyo’s Regulations for Animal Care and Use and were approved by the Animal Experiment Committee of the Institute of Medical Science, the University of Tokyo (PA20-6).

2.6. Statistical Analysis

For statistical analyses of growth kinetics data, the virus titer values were converted to the log10 scale, and a two-way ANOVA, followed by a Dunnett’s test, was performed. The virus titers of Ck/HE28-50 were compared with those of Ck/HE28-57, and the difference was considered significant for p values of <0.05 in GraphPad Prism6.

3. Results

3.1. Replicative Ability of Two H9N2 Avian Influenza Viruses In Vitro Subsection

Two H9N2 viruses (Ck/HE28-50 and Ck/HE28-57) were previously isolated from chicken meat products transported by international flight passengers from Vietnam to Japan in 2016 [14] and found to be Y280 lineage H9N2 viruses with an HA cleavage site (PSRSSR/GLF) typical of low pathogenic avian influenza viruses. We found that both Ck/HE28-50 and Ck/HE28-57 possess several molecular markers in their proteins that are associated with the adaptation of avian influenza viruses in mammals (i.e., 5 amino acids in PB2, 1 in PB1, 3 in PA, 4 in HA, 3 in M1, and 3 in NS; as shown in Table 1 and Supplementary Table S1) [17,18,19,20,21]. Moreover, Ck/HE28-57 possesses three additional molecular markers with mammalian-like motifs at positions 292 and 340 in PB2 and 160 in HA (Table 1 and Supplementary Table S1). These viruses were propagated in embryonated chicken eggs to produce viral stocks. The stock titers of Ck/HE28-50 and Ck/HE28-57 were 9.64 log10 PFU/mL and 9.61 log10 PFU/mL, respectively.
To characterize the replicative ability of the H9N2 viruses in vitro, we examined their growth kinetics in chicken embryo fibroblast DF-1 cells and mammalian (MDCK and A549) cells. In DF-1 cells, Ck/HE28-50 and Ck/HE28-57 both grew well at 39 °C, with peak titers of 7.38 ± 0.09 log10 PFU/mL and 7.39 ± 0.09 log10 PFU/mL, respectively, at 24 hpi (Figure 1A). In MDCK cells, both viruses replicated well at 37 °C, but the peak titer of Ck/HE28-57 was slightly higher than that of Ck/HE28-50 (i.e., 8.03 ± 0.09 log10 PFU/mL and 8.70 ± 0.07 log10 PFU/mL at 24 hpi, respectively) (Figure 1B). In contrast, in human lung A549 cells, Ck/HE28-57 replicated more efficiently than Ck/HE28-50 at 37 °C, with a peak titer 2-log higher than that of Ck/HE28-50 (i.e., 7.59 ± 0.08 log10 PFU/mL cf. 5.70 ± 0.36 log10 PFU/mL) (Figure 1C). These results demonstrate that Ck/HE28-57 replicates more efficiently than Ck/HE28-50 in MDCK and human lung A549 cells, but both viruses grow equally well in DF-1 cells.

3.2. Replicative Ability and Pathogenicity of Two H9N2 Avian Influenza Viruses in Mice

We next examined the replicative ability of these H9N2 viruses in vivo. C57BL/6 mice were intranasally infected with 104 PFU or 106 PFU of Ck/HE28-50 or Ck/HE28-57, and organ samples were collected at 3 and 6 dpi for virus titration. In mice infected with 106 PFU of the virus, both viruses replicated well in the lungs and nasal turbinates. The mean virus titers in the lungs of mice infected with Ck/HE28-50 or Ck/HE28-57 were 6.25 ± 0.42 and 6.70 ± 0.20 log10 PFU/g at 3 dpi, respectively, and those in the nasal turbinates were 4.87 ± 0.40 and 5.31 ± 0.77 log10 PFU/g at 3 dpi, respectively, for the Ck/HE28-50 and Ck/HE28-57 groups (Figure 2A). For the mice infected with 104 PFU of the virus, the mean lung titers of the Ck/HE28-50- or Ck/HE28-57-infected mice were 4.32 ± 0.56 and 5.25 ± 0.26 log10 PFU/g, respectively, at 6 dpi. In the nasal turbinate, the mean virus titer of Ck/HE28-57-infected mice was 4.22 ± 0.38 log10PFU/g at 6 dpi, whereas virus (2.52 log10 PFU/g) was recovered from only one of the three mice infected with Ck/HE28-50 (Figure 2B).
To examine the pathogenicity of the two H9N2 viruses, five C57BL/6 mice per group were inoculated intranasally with 106 PFU of each virus, and their body weight changes were monitored for 14 days (Figure 3). The Ck/HE28-50-infected mice continued to gain body weight during the observation period, as did the control group, which was inoculated intranasally with 50 μL/mouse of PBS. In contrast, the body weight of the Ck/HE28-57-infected mice declined by day 7 post-infection (Figure 3); however, all mice recovered from their infection with Ck/HK28/57.

4. Discussion

In this study, we examined the biological features of two H9N2 viruses (Ck/HE28-50 and Ck/HE28-57) that were isolated from raw poultry meat that was illegally brought into Japan from Vietnam [14]. We found that these H9N2 viruses replicate reasonably well in mammalian cells and mice, although the replicative ability of Ck/HE28-50 was lower than that of Ck/HE28-57 in A549 cells (Figure 1). Concerning pathogenicity in mice, Ck/HE28-57 caused a temporary loss of body weight, whereas the body weight of Ck/HE28-50-infected mice gradually increased similarly to the mock-infected group (Figure 3). These data demonstrate that Ck/HE28-50 and Ck/HE28-57 can replicate in mammals and that Ck/HE28-57 is slightly more virulent than Ck/HE28-50 in mammalian hosts.
Avian influenza viruses rarely infect humans due to host range restrictions. Several viral factors determine the viral interspecies transmission and pathogenicity of avian influenza viruses in mammals [17,18,19,20,21]. The receptor-binding specificity of the HA protein is a major determinant of the influenza viral host range [19,22,23,24]. In general, human influenza viruses preferentially bind to sialic acid-α2,6-galactose (SAα2,6Gal), the predominant sialyloligosaccharide species on epithelial cells in the upper respiratory tract of humans [19,25], whereas avian influenza viruses preferentially recognize sialic acid-α2,3-galactose (SAα2,3Gal), the major sialyloligosaccharide species in the duck intestinal tract [26]. A change of binding preference from the avian-type receptor (i.e., SAα2,3Gal) to the human-like receptor (i.e., SAα2,6Gal) is considered to be one of the important steps for the adaptation of avian influenza viruses to mammalian hosts [22,24,25,27]. There are several key residues in HA that affect viral receptor-binding preference; for example, replacing glutamine (Q) with leucine (L) at position 226 (H3 numbering), which is found in most H9N2 poultry isolates, can alter the viral receptor-binding preference from the avian-type receptor to the human-type receptor [23]. Ck/HE28-50 and Ck/HE28-57 possess four amino acid substitutions in HA (i.e., HA-159N, HA-190V, HA-198T, and HA-226L) that are associated with a shift in the binding preference of avian influenza viruses to the human-type receptor (Supplementary Table S1) [23,24,28,29]. In addition, the viral polymerase complex, which comprises PB2, PB1, PA, and NP, has key roles in the adaptation of avian influenza viruses to mammalian hosts, and several amino acid substitutions have been shown to contribute to increased polymerase activity, replicative ability, and/or virulence in mammalian models [20,30,31,32,33,34]. The change from glutamic acid (E) to lysine (K) at position 627 of the PB2 protein is one of the most important host range determinants, but neither Ck/HE28-50 nor Ck/HE28-57 possesses the E-to-K change at position 627 of PB2. Instead, they have several amino acid substitutions in the viral polymerase complex that are associated with the mammalian adaptation and pathogenicity of avian influenza viruses (i.e., PB2-89V and 309D, PB2-504V, PB2-588V, PB1-622G, PA-63I, PA-356R, and PA-383D) (Supplementary Table S1) [20,21,31,33,34,35,36]. Ck/HE28-57, but not Ck/HE28-50, possesses the isoleucine (I)-to-valine (V) mutation at position 292 of PB2 protein that is associated with increased H9N2 virus polymerase activity in mammalian cells and enhanced virulence in mice [37]. In our study, Ck/HE28-57 was more pathogenic than Ck/HE28-50 in mice (Figure 3), indicating that PB2-292V may contribute to the increased virulence of Ck/HE28-57 in the mouse model. Alternatively, an as-of-yet undetermined amino acid change(s) in Ck/HE28-57 may have a role in its pathogenicity in mice. Further studies are needed to clarify the factors that determine the differences between the properties of Ck/HE28-50 and Ck/HE28-57.
Compared with highly pathogenic avian influenza viruses, such as H5N1 and H7N9 viruses, less attention is paid to low pathogenic avian influenza viruses. However, many reports, including this study, have described the capability of H9N2 viruses to adapt to mammals [23,24,30,33,37,38,39], raising concern about their pandemic potential. Even though H9N2 avian viruses have not yet been isolated in domestic poultry in Japan, enhanced surveillance at the border is essential to prevent their spread.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/v14040728/s1, Table S1: Molecular markers in viral proteins associated with adaptation of avian influenza viruses to mammalian hosts.

Author Contributions

J.M., M.I., T.W. and Y.K. designed the study. J.M. and T.W. performed the experiments. J.M., A.S., G.N., M.I., T.W. and Y.K. analyzed the data and wrote the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) Collaborative Awards 2019 from the Japan Agency for Medical Research and Development (AMED) (JP20jk0210021h0002), by Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan (Nos. 16H06429, 16K21723, and 16H06434), by the Japan Program for Infectious Diseases Research and Infrastructure (JP21wm0125002), and by the NIAID-funded Center for Research on Influenza Pathogenesis (CRIP, HHSN272201400008C).

Institutional Review Board Statement

All experiments with mice were performed in accordance with the University of Tokyo’s Regulations for Animal Care and Use and were approved by the Animal Experiment Committee of the Institute of Medical Science, the University of Tokyo (PA20-6).

Acknowledgments

We thank Susan Watson for editing the manuscript. We also thank Mutsumi Ito, Hiroyuki Osaka, and Riho Sumiyoshi for technical support.

Conflicts of Interest

Y.K. has received grant support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, Fuji Rebio. All of the other authors declare they have no conflict of interest.

References

  1. Hassan, M.S.H.; Abdul-Careem, M.F. Avian Viruses that Impact Table Egg Production. Animals 2020, 10, 1747. [Google Scholar] [CrossRef]
  2. Smithies, L.K.; Radloff, D.B.; Friedell, R.W.; Albright, G.W.; Misner, V.E.; Easterday, B.C. Two Different Type A Influenza Virus Infections in Turkeys in Wisconsin, I. 1965–66 Outbreak. Avian Dis. 1969, 13, 603. [Google Scholar] [CrossRef]
  3. Homme, P.J.; Easterday, B.C. Avian Influenza Virus Infections. I. Characteristics of Influenza A/Turkey/Wisconsin/1966 Virus. Avian Dis. 1970, 14, 66. [Google Scholar] [CrossRef] [PubMed]
  4. Carnaccini, S.; Perez, D.R. H9 Influenza Viruses: An Emerging Challenge. Cold Spring Harb Perspect Med. 2020, 10, a038588. [Google Scholar] [CrossRef] [PubMed]
  5. Peiris, M.; Yuen, K.; Leung, C.; Chan, K.; Ip, P.; Lai, R.; Orr, W.; Shortridge, K. Human infection with influenza H9N2. Lancet 1999, 354, 916–917. [Google Scholar] [CrossRef]
  6. World Health Organization. Influenza at the Human-Animal Interface Summary and Assessment, from 21 January to 28 February 2020; World Health Organization: Geneva, Switzerland, 2020; pp. 1–2. [Google Scholar]
  7. World Health Organization. Influenza at the Human-Animal Interface Summary and Assessment, from 28 September 2019 to 25 November 2019; World Health Organization: Geneva, Switzerland, 2019; pp. 1–2. [Google Scholar]
  8. Guan, Y.; Shortridge, K.F.; Krauss, S.; Chin, P.S.; Dyrting, K.C.; Ellis, T.M.; Webster, R.G.; Peiris, M. H9N2 Influenza Viruses Possessing H5N1-Like Internal Genomes Continue To Circulate in Poultry in Southeastern China. J. Virol. 2000, 74, 9372–9380. [Google Scholar] [CrossRef] [Green Version]
  9. Lin, Y.P.; Shaw, M.; Gregory, V.; Cameron, K.; Lim, W.; Klimov, A.; Subbarao, K.; Guan, Y.; Krauss, S.; Shortridge, K.; et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates. Proc. Natl. Acad. Sci. USA 2000, 97, 9654–9658. [Google Scholar] [CrossRef] [Green Version]
  10. To, K.K.; Chan, J.F.; Chen, H.; Li, L.; Yuen, K.-Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: A tale of two cities. Lancet Infect. Dis. 2013, 13, 809–821. [Google Scholar] [CrossRef]
  11. Su, S.; Bi, Y.; Wong, G.; Gray, G.C.; Gao, G.F.; Li, S. Epidemiology, Evolution, and Recent Outbreaks of Avian Influenza Virus in China. J. Virol. 2015, 89, 8671–8676. [Google Scholar] [CrossRef] [Green Version]
  12. Guo, Y.J.; Krauss, S.; Senne, D.A.; Mo, I.P.; Lo, K.S.; Xiong, X.P.; Norwood, M.; Shortridge, K.F.; Webster, R.G.; Guan, Y. Characterization of the Pathogenicity of Members of the Newly Established H9N2 Influenza Virus Lineages in Asia. Virology 2000, 267, 279–288. [Google Scholar] [CrossRef] [Green Version]
  13. Guan, Y.; Shortridge, K.F.; Krauss, S.; Webster, R.G. Molecular characterization of H9N2 influenza viruses: Were they the donors of the “internal” genes of H5N1 viruses in Hong Kong? Proc. Natl. Acad. Sci. USA 1999, 96, 9363–9367. [Google Scholar] [CrossRef] [Green Version]
  14. Shibata, A.; Okamatsu, M.; Sumiyoshi, R.; Matsuno, K.; Wang, Z.-J.; Kida, H.; Osaka, H.; Sakoda, Y. Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers. Virology 2018, 524, 10–17. [Google Scholar] [CrossRef]
  15. Shibata, A.; Hiono, T.; Fukuhara, H.; Sumiyoshi, R.; Ohkawara, A.; Matsuno, K.; Okamatsu, M.; Osaka, H.; Sakoda, Y. Isolation and characterization of avian influenza viruses from raw poultry products illegally imported to Japan by international flight passengers. Transbound Emerg. Dis. 2018, 65, 465–475. [Google Scholar] [CrossRef]
  16. Hoffmann, E.; Stech, J.; Guan, Y.; Webster, R.G.; Perez, D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146, 2275–2289. [Google Scholar] [CrossRef]
  17. Belser, J.A.; Gustin, K.M.; Pearce, M.B.; Maines, T.R.; Zeng, H.; Pappas, C.; Sun, X.; Carney, P.J.; Villanueva, J.M.; Stevens, J.; et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 2013, 501, 556–559. [Google Scholar] [CrossRef]
  18. Chen, L.-M.; Blixt, O.; Stevens, J.; Lipatov, A.S.; Davis, C.T.; Collins, B.E.; Cox, N.J.; Paulson, J.C.; Donis, R.O. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology 2012, 422, 105–113. [Google Scholar] [CrossRef] [Green Version]
  19. Shinya, K.; Ebina, M.; Yamada, S.; Ono, M.; Kasai, N.; Kawaoka, Y. Influenza virus receptors in the human airway. Nature 2006, 440, 435–436. [Google Scholar] [CrossRef]
  20. Li, J.; Ishaq, M.; Prudence, M.; Xi, X.; Hu, T.; Liu, Q.; Guo, D. Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2. Virus Res. 2009, 144, 123–129. [Google Scholar] [CrossRef]
  21. Song, J.; Xu, J.; Shi, J.; Li, Y.; Chen, H. Synergistic Effect of S224P and N383D Substitutions in the PA of H5N1 Avian Influenza Virus Contributes to Mammalian Adaptation. Sci. Rep. 2015, 5, 10510. [Google Scholar] [CrossRef] [Green Version]
  22. Rogers, G.N.; Paulson, J.C.; Daniels, R.S.; Skehel, J.J.; Wilson, I.A.; Wiley, D.C. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 1983, 304, 76–78. [Google Scholar] [CrossRef]
  23. Wan, H.; Perez, D.R. Amino Acid 226 in the Hemagglutinin of H9N2 Influenza Viruses Determines Cell Tropism and Replication in Human Airway Epithelial Cells. JVI 2007, 81, 5181–5191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Teng, Q.; Xu, D.; Shen, W.; Liu, Q.; Rong, G.; Li, X.; Yan, L.; Yang, J.; Chen, H.; Yu, H.; et al. A Single Mutation at Position 190 in Hemagglutinin Enhances Binding Affinity for Human Type Sialic Acid Receptor and Replication of H9N2 Avian Influenza Virus in Mice. J. Virol. 2016, 90, 9806–9825. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. H5N1 Virus Attachment to Lower Respiratory Tract. Science 2006, 312, 399. [CrossRef] [Green Version]
  26. Suzuki, Y.; Ito, T.; Suzuki, T.; Holland, R.E.; Chambers, T.M.; Kiso, M.; Ishida, H.; Kawaoka, Y. Sialic Acid Species as a Determinant of the Host Range of Influenza A Viruses. J. Virol. 2000, 74, 11825–11831. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127, 361–373. [CrossRef]
  28. Wang, W.; Lu, B.; Zhou, H.; Suguitan, A.L.; Cheng, X.; Subbarao, K.; Kemble, G.; Jin, H. Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in Ferrets. J. Virol. 2010, 84, 6570–6577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Kaverin, N.V.; Rudneva, I.A.; Ilyushina, N.A.; Lipatov, A.S.; Krauss, S.; Webster, R.G. Structural Differences among Hemagglutinins of Influenza A Virus Subtypes Are Reflected in Their Antigenic Architecture: Analysis of H9 Escape Mutants. J. Virol. 2004, 78, 240–249. [Google Scholar] [CrossRef] [Green Version]
  30. Kamiki, H.; Matsugo, H.; Kobayashi, T.; Ishida, H.; Takenaka-Uema, A.; Murakami, S.; Horimoto, T. A PB1-K577E Mutation in H9N2 Influenza Virus Increases Polymerase Activity and Pathogenicity in Mice. Viruses 2018, 10, 653. [Google Scholar] [CrossRef] [Green Version]
  31. Hu, M.; Chu, H.; Zhang, K.; Singh, K.; Li, C.; Yuan, S.; Chow, B.K.C.; Song, W.; Zhou, J.; Zheng, B.-J. Amino acid substitutions V63I or A37S/I61T/V63I/V100A in the PA N-terminal domain increase the virulence of H7N7 influenza A virus. Sci. Rep. 2016, 6, 37800. [Google Scholar] [CrossRef] [Green Version]
  32. Yamayoshi, S.; Fukuyama, S.; Yamada, S.; Zhao, D.; Murakami, S.; Uraki, R.; Watanabe, T.; Tomita, Y.; Neumann, G.; Kawaoka, Y. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci. Rep. 2015, 5, 8039. [Google Scholar] [CrossRef]
  33. Xu, G.; Zhang, X.; Gao, W.; Wang, C.; Wang, J.; Sun, H.; Sun, Y.; Guo, L.; Zhang, R.; Chang, K.-C.; et al. Prevailing PA Mutation K356R in Avian Influenza H9N2 Virus Increases Mammalian Replication and Pathogenicity. J. Virol. 2016, 90, 8105–8114. [Google Scholar] [CrossRef] [Green Version]
  34. Feng, X.; Wang, Z.; Shi, J.; Deng, G.; Kong, H.; Tao, S.; Li, C.; Liu, L.; Guan, Y.; Chen, H. Glycine at Position 622 in PB1 Contributes to the Virulence of H5N1 Avian Influenza Virus in Mice. J. Virol. 2016, 90, 1872–1879. [Google Scholar] [CrossRef] [Green Version]
  35. Kandeil, A.; El-Shesheny, R.; Maatouq, A.M.; Moatasim, Y.; Shehata, M.M.; Bagato, O.; Rubrum, A.; Shanmuganatham, K.; Webby, R.J.; Ali, M.A.; et al. Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013. Arch. Virol. 2014, 159, 2861–2876. [Google Scholar] [CrossRef]
  36. Xiao, C.; Ma, W.; Sun, N.; Huang, L.; Li, Y.; Zeng, Z.; Wen, Y.; Zhang, Z.; Li, H.; Li, Q.; et al. PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses. Sci. Rep. 2016, 6, 19474. [Google Scholar] [CrossRef] [Green Version]
  37. Gao, W.; Zu, Z.; Liu, J.; Song, J.; Wang, X.; Wang, C.; Liu, L.; Tong, Q.; Wang, M.; Sun, H.; et al. Prevailing I292V PB2 mutation in avian influenza H9N2 virus increases viral polymerase function and attenuates IFN-β induction in human cells. J. Gen. Virol. 2019, 100, 1273–1281. [Google Scholar] [CrossRef]
  38. Wan, H.; Sorrell, E.M.; Song, H.; Hossain, M.J.; Ramirez-Nieto, G.; Monne, I.; Stevens, J.; Cattoli, G.; Capua, I.; Chen, L.-M.; et al. Replication and Transmission of H9N2 Influenza Viruses in Ferrets: Evaluation of Pandemic Potential. PLoS ONE 2008, 3, e2923. [Google Scholar] [CrossRef] [Green Version]
  39. Li, X.; Shi, J.; Guo, J.; Deng, G.; Zhang, Q.; Wang, J.; He, X.; Wang, K.; Chen, J.; Li, Y.; et al. Genetics, Receptor Binding Property, and Transmissibility in Mammals of Naturally Isolated H9N2 Avian Influenza Viruses. PLoS Pathog 2014, 10, e1004508. [Google Scholar] [CrossRef]
Viruses 14 00728 g001 550
Figure 1. Replicative ability of two H9N2 viruses in DF-1, MDCK, and A549 cells. DF-1 (A), MDCK (B), and A549 (C) cells were infected with Ck/HE28-50 or Ck/HE28-57 at a multiplicity of infection of 0.001 and incubated at the indicated temperatures. Virus titers are presented as the mean ± standard deviation (SD) of two independent experiments. * indicates p < 0.05 Ck/HE28-50 versus Ck/HE28-57.
Figure 1. Replicative ability of two H9N2 viruses in DF-1, MDCK, and A549 cells. DF-1 (A), MDCK (B), and A549 (C) cells were infected with Ck/HE28-50 or Ck/HE28-57 at a multiplicity of infection of 0.001 and incubated at the indicated temperatures. Virus titers are presented as the mean ± standard deviation (SD) of two independent experiments. * indicates p < 0.05 Ck/HE28-50 versus Ck/HE28-57.
Viruses 14 00728 g001
Viruses 14 00728 g002 550
Figure 2. Virus titers in mice infected with H9N2 avian influenza viruses. Three mice per group were intranasally inoculated with (A) 106 PFU (in 50 μL) or (B) 104 PFU (in 50 μL) of Ck/HE28-50 or Ck/HE28-57. Lung and nasal turbinate tissues were collected from the infected mice at 3 and 6 days post-infection for virus titration. Each circle represents the virus titer of an individual sample. The bar indicates the mean and is shown only when the virus was recovered from all three mice. The lower limit of detection is indicated by the horizontal dashed line.
Figure 2. Virus titers in mice infected with H9N2 avian influenza viruses. Three mice per group were intranasally inoculated with (A) 106 PFU (in 50 μL) or (B) 104 PFU (in 50 μL) of Ck/HE28-50 or Ck/HE28-57. Lung and nasal turbinate tissues were collected from the infected mice at 3 and 6 days post-infection for virus titration. Each circle represents the virus titer of an individual sample. The bar indicates the mean and is shown only when the virus was recovered from all three mice. The lower limit of detection is indicated by the horizontal dashed line.
Viruses 14 00728 g002
Viruses 14 00728 g003 550
Figure 3. Body weight changes in mice infected with H9N2 avian influenza viruses. Five mice per group were intranasally inoculated with 106 PFU (in 50 μL) of Ck/HE28-50, Ck/HE28-57, or PBS as a control. Body weights were measured daily for 14 days and are presented as means ± SD.
Figure 3. Body weight changes in mice infected with H9N2 avian influenza viruses. Five mice per group were intranasally inoculated with 106 PFU (in 50 μL) of Ck/HE28-50, Ck/HE28-57, or PBS as a control. Body weights were measured daily for 14 days and are presented as means ± SD.
Viruses 14 00728 g003
Table
Table 1. Molecular markers associated with the adaptation of avian influenza viruses to mammalian hosts found in the viral proteins of the H9N2 viruses Ck/HE28-50 and Ck/HE28-57 a.
Table 1. Molecular markers associated with the adaptation of avian influenza viruses to mammalian hosts found in the viral proteins of the H9N2 viruses Ck/HE28-50 and Ck/HE28-57 a.
ProteinAmino AcidViruses Tested in This StudyPhenotypeSubtypes Tested
ResidueAvian-
like Motif		Mammalian-like MotifCk/HE28-50Ck/HE28-57
PB2292IVIVIncreased polymerase activity in mammalian and avian cell lines, increased virulence in miceH9N2
Increased polymerase activity in mammalian cell lineH10N8
504IVVVIncreased virulence in miceH9
588AVVVIncreased polymerase activity and replication in mammalian and avian cell lines, increased virulence in miceH7N9, H9N2, H10N8
89, 30989LVVVIncreased polymerase activity and replication in mammalian cells, increased virulence in miceH5N1
309GDDD
340,588340RKRKTransmission in guinea pigsH9N2
588AVVV
PB1622DGGGIncreased polymerase activity and enhanced replication in mammalian cell line, increased virulence in miceH5N1
PA63VIIIIncreased polymerase activity and enhanced replication in mammalian cell line, increased virulence in miceH7N7
356KRRRIncreased polymerase activity and replication in mammalian cell line, increased virulence in miceH9N2
383NDDDIncreased polymerase activity in avian and mammalian cell linesH5N1
HA159SNNNIncreased virus binding to α2-6SAH5N1
160TATAIncreased virus binding to α2-6SA,
increased transmission ability in guinea pigs		H5N1
190TVVVEnhanced binding affinity to mammalian cells and replication in mammalian cellsH9N2
198NTTTIncrease replication and transmission in ferretsH9
226QLLLIncreased virus binding to α2-6SA, enhanced replication in mammalian cells and ferrets, enhanced contact transmission in ferretsH9N2
M130NDDDIncreased virulence in miceH5N1
43IMMMIncreased virulence in mice, chickens, and ducksH5N1
215TAAAIncreased virulence in miceH5N1
NS42PSSSIncreased virulence in miceH5N1
138CFFFIncreased replication mammalian cells, decreased
interferon response		H5N1
149VAAAIncreased virulence and decreased interferon responseH5N1
a, Two H9N2 viruses (Ck/HE28-50 and Ck/HE28-57) possess molecular markers in their viral proteins that are associated with the adaptation of avian influenza viruses to mammalian hosts. A comprehensive list is provided in Supplementary Table S1, with references. HA residue positions are presented with H3 HA numbering.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Murakami, J.; Shibata, A.; Neumann, G.; Imai, M.; Watanabe, T.; Kawaoka, Y. Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model. Viruses 2022, 14, 728. https://doi.org/10.3390/v14040728

AMA Style

Murakami J, Shibata A, Neumann G, Imai M, Watanabe T, Kawaoka Y. Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model. Viruses. 2022; 14(4):728. https://doi.org/10.3390/v14040728

Chicago/Turabian Style

Murakami, Jurika, Akihiro Shibata, Gabriele Neumann, Masaki Imai, Tokiko Watanabe, and Yoshihiro Kawaoka. 2022. "Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model" Viruses 14, no. 4: 728. https://doi.org/10.3390/v14040728

APA Style

Murakami, J., Shibata, A., Neumann, G., Imai, M., Watanabe, T., & Kawaoka, Y. (2022). Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model. Viruses, 14(4), 728. https://doi.org/10.3390/v14040728

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop